Discontinued — last reported Q4 '25
Cardinal Health Acquisitions decreased by 97.8% to $42.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 98.5%, from $2.78B to $42.00M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 546.8% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $750.00K | $5.50M | $5.50M | $5.50M | $5.50M | $2.50M | $2.50M | $2.50M | $2.50M | $297.50M | $297.50M | $297.50M | $297.50M | $0.00 | $1.08B | $2.78B | $1.40B | $41.00M | $1.88B | $42.00M |
| QoQ Change | — | +633.3% | +0.0% | +0.0% | +0.0% | -54.5% | +0.0% | +0.0% | +0.0% | >999% | +0.0% | +0.0% | +0.0% | -100.0% | — | +158.3% | -49.8% | -97.1% | >999% | -97.8% |
| YoY Change | — | — | — | — | +633.3% | -54.5% | -54.5% | -54.5% | -54.5% | >999% | >999% | >999% | >999% | -100.0% | +261.7% | +834.1% | +368.9% | — | +75.1% | -98.5% |